Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M297Revenue $M15.5Net Margin (%)-197.1Z-Score4.1
Enterprise Value $M188EPS $-0.8Operating Margin %-136.9F-Score3
P/E(ttm))0Cash Flow Per Share $-0.8Pre-tax Margin (%)-197.1Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %-1.7Quick Ratio5.7Cash flow > EarningsY
Price/Sales15.15-y EBITDA Growth Rate %-1.0Current Ratio5.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-34.9Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-45.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M22.3ROI % (ttm)148Gross Margin Increase y-yN

Gurus Latest Trades with TKMR

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
TKMRJean-Marie Eveillard 2013-06-30 Sold Out $4.28 - $5.05
($4.74)
$ 13.32181%Sold Out0
TKMRJean-Marie Eveillard 2013-03-31 Buy $4.35 - $5.44
($4.73)
$ 13.32182%New holding, 25000 sh.25,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

TKMR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


TKMR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lutwyche, PeterDirector or Senior Officer of Insider or Subsidiar 2014-12-01Sell18,000$18.43-27.73view
Phillips, Peggy VanSiceDirector 2014-06-19Buy5,000$13.6-2.06view
Phillips, Peggy VanSiceDirector 2014-06-18Buy5,000$13.6-2.06view
Jewell, DonaldDirector 2014-06-16Buy2,450$14.14-5.8view
Jewell, DonaldDirector 2013-08-06Buy300$6.09118.72view
Jewell, DonaldDirector 2013-08-06Buy500$6.1118.36view
Jewell, DonaldDirector 2013-08-06Buy400$6.09118.72view
Jewell, DonaldDirector 2013-08-06Buy400$6.1118.36view
Murray, Mark JosephSenior Officer 2013-04-16Buy5,000$4.6189.57view
Jewell, DonaldDirector 2013-03-12Buy1,200$4.44200view

Press Releases about TKMR :

    Quarterly/Annual Reports about TKMR:

    News about TKMR:

    Articles On GuruFocus.com
    Tekmira Pharmaceuticals Gets Mixed Ratings After Ebola Drug Updates Nov 11 2014 
    Ebola: Is The Cure Out There? Oct 14 2014 
    Ebola Diagnosis in U.S. Raises Pharmaceutical Stock by 20% Oct 01 2014 

    More From Other Websites
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other... Dec 19 2014
    Tekmira Pharmaceuticals Announces Leadership Changes Dec 19 2014
    Tekmira Pharmaceuticals Announces Leadership Changes Dec 19 2014
    The Ebola Treatment You Haven't Heard Of Dec 19 2014
    12:50 am Tekmira Pharma files shelf registration for up to $150 mln Nov 30 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events Nov 28 2014
    Tekmira Files Shelf Registration Statement Nov 26 2014
    Tekmira Files Shelf Registration Statement Nov 26 2014
    Merck, Iowa firm sign Ebola vaccine licensing deal Nov 24 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events Nov 24 2014
    Lightning Round: You're playing with fire Nov 21 2014
    Tekmira Provides Key Highlights of Analyst and Investor Day in New York Nov 21 2014
    Tekmira Provides Key Highlights of Analyst and Investor Day in New York Nov 21 2014
    4 More Biotech Stocks to Buy, With Up to 200% Upside Nov 21 2014
    Tekmira Pharmaceuticals (TKMR) Showing Signs Of Perilous Reversal Today Nov 18 2014
    Tekmira Announces Licensing and Collaboration Agreement With Dicerna Nov 17 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 17 2014
    Tekmira Announces Licensing and Collaboration Agreement With Dicerna Nov 17 2014
    TEKMIRA PHARMACEUTICALS CORP Financials Nov 14 2014
    TEKMIRA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 13 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK